- Tytuł:
- Urology in 2020. PARP inhibitors make clinical splash as COVID-19's impact is felt throughout specialty. (cover story)
- Autorzy:
- Temat:
-
THERAPEUTIC use of monoclonal antibodies
DRUG approval
BLADDER tumors
GENETIC mutation
FEMALE reproductive organ diseasesSEXUAL dysfunction
METASTASIS
UNITED States. Food & Drug Administration
OVERACTIVE bladder
MALE reproductive organ diseases
UROLOGY
COVID-19 pandemic
ENZYME inhibitors
PROSTATE tumors - Źródło:
-
Urology Times . Dec2020, Vol. 48 Issue 12, p1-18. 4p.
Periodyk